GLP-1
WHO Endorses GLP-1 Drugs for Weight Loss in Major Policy Shift
Popular drugs like Ozempic are now a part of official global health recommendations from the World Health Organization to treat obesity.
GNC Pushes To Make Supplements Part of the GLP-1 Conversation
GNC's new peer-reviewed research shows how supplements can support GLP-1 takers in preserving muscle mass loss and plugging nutrition gaps.
Why America’s Obesity Crisis Is Complicated
While obesity rates have fallen in some U.S. States, researchers warn that current definitions don't paint a full picture of America's weight crisis.
GLP-1s May Be Blunting the Buzz & Changing How We Drink
A preliminary study shows GLP-1 drugs like Ozempic may slow alcohol absorption and reduce feelings of intoxication.
America’s Obesity Crisis Is Much Worse Than You Think, Researchers Warn
Under a new definition of obesity endorsed by the The American Heart Association, 70% of Americans are obese, up from 40% currently.
As Starbucks Goes All-In Protein, GLP-1 Users Face Muscle-Loss Risks
Starbucks has launched protein lattes, but Jessica Crandall, RDN, shares why protein, fiber and a care plan matter most for GLP-1 users.
Rebel Wilson, Noom Partner as GLP-1s Enter Microdose Era
Rebel Wilson joins Noom as chief wellness ambassador, backing its new free tier that gamifies healthy habits and spotlights microdose GLP-1s.
ATN Week in Review: Apple Is Serious About Fitness & Wellness
Apple keeps pushing into the fitness and wellness industry, and it’s hard to say just where the tech giant will stop.
Americans Are Conflicted on the Long-Term Effects of GLP-1s, Data Shows
While Americans see the benefits of GLP-1s, skepticism about relying on an injection to lose weight still runs deep, a new survey finds.
GLP-1s Are Most Popular in These US Cities, Report Finds
Search trends and survey data show where interest in weight loss drugs like Ozempic and Wegovy is surging in America.
